Alaunos Acquires Velaris in $350 Million Private Placement
Alaunos Therapeutics reported the acquisition of Velaris Therapeutics and a $350 million private placement led by Fairmount. Its shares more than doubled to $2.92.
Alaunos Therapeutics shares surged after the company said it had acquired Velaris Therapeutics and secured a $350 million private placement led by Fairmount. 92, though it remains down about 9% this year. Velaris is developing drugs for pulmonary arteria…